Avid Bioservices Inc (CDMO)

[pphmtoolong]

geocappy1, I fully expected Sunrise to succeed. It didn't. No point in pretending otherwise.

Let's move on to the new reality. Bavi now faces back to early phase trials, assuming the researchers Peregrine hired give the positive reports we'd like to see.

Meanwhile, Peregrine cannot spend money like they have for the last few years, when they expected FDA approval of Bavi in 2017.

If they can't get a Bavi partner, Bavi development will either be funded by two years of punishing dilution or it will be slowly advanced by whatever profits Avid can generate.

I don't like it, but these tea leaves aren't that hard to read.

GLTA, Paul